vs

Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

FREQUENCY ELECTRONICS INC is the larger business by last-quarter revenue ($17.1M vs $13.3M, roughly 1.3× OCULAR THERAPEUTIX, INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -488.0%, a 498.5% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs -22.4%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-57.1M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs -5.3%).

Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

FEIM vs OCUL — Head-to-Head

Bigger by revenue
FEIM
FEIM
1.3× larger
FEIM
$17.1M
$13.3M
OCUL
Growing faster (revenue YoY)
FEIM
FEIM
+30.7% gap
FEIM
8.3%
-22.4%
OCUL
Higher net margin
FEIM
FEIM
498.5% more per $
FEIM
10.5%
-488.0%
OCUL
More free cash flow
FEIM
FEIM
$56.0M more FCF
FEIM
$-1.1M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
FEIM
FEIM
Annualised
FEIM
11.8%
-5.3%
OCUL

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FEIM
FEIM
OCUL
OCUL
Revenue
$17.1M
$13.3M
Net Profit
$1.8M
$-64.7M
Gross Margin
38.2%
88.0%
Operating Margin
10.0%
-526.5%
Net Margin
10.5%
-488.0%
Revenue YoY
8.3%
-22.4%
Net Profit YoY
-32.1%
-33.6%
EPS (diluted)
$0.18
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FEIM
FEIM
OCUL
OCUL
Q4 25
$17.1M
$13.3M
Q3 25
$13.8M
$14.5M
Q2 25
$20.0M
$13.5M
Q1 25
$18.9M
$10.7M
Q4 24
$15.8M
$17.1M
Q3 24
$15.1M
$15.4M
Q2 24
$15.6M
$16.4M
Q1 24
$13.7M
$14.8M
Net Profit
FEIM
FEIM
OCUL
OCUL
Q4 25
$1.8M
$-64.7M
Q3 25
$634.0K
$-69.4M
Q2 25
$3.2M
$-67.8M
Q1 25
$15.4M
$-64.1M
Q4 24
$2.7M
$-48.4M
Q3 24
$2.4M
$-36.5M
Q2 24
$2.6M
$-43.8M
Q1 24
$130.0K
$-64.8M
Gross Margin
FEIM
FEIM
OCUL
OCUL
Q4 25
38.2%
88.0%
Q3 25
36.8%
87.8%
Q2 25
37.5%
85.6%
Q1 25
43.8%
88.2%
Q4 24
48.2%
92.8%
Q3 24
44.4%
89.9%
Q2 24
40.3%
90.8%
Q1 24
22.6%
91.0%
Operating Margin
FEIM
FEIM
OCUL
OCUL
Q4 25
10.0%
-526.5%
Q3 25
2.6%
-472.3%
Q2 25
16.4%
-502.6%
Q1 25
18.3%
-597.5%
Q4 24
16.5%
-296.1%
Q3 24
15.7%
-298.2%
Q2 24
16.0%
-265.1%
Q1 24
-3.4%
-214.0%
Net Margin
FEIM
FEIM
OCUL
OCUL
Q4 25
10.5%
-488.0%
Q3 25
4.6%
-477.3%
Q2 25
16.0%
-503.9%
Q1 25
81.4%
-598.7%
Q4 24
16.8%
-283.3%
Q3 24
16.1%
-236.6%
Q2 24
16.9%
-266.3%
Q1 24
0.9%
-438.9%
EPS (diluted)
FEIM
FEIM
OCUL
OCUL
Q4 25
$0.18
$-0.27
Q3 25
$0.07
$-0.38
Q2 25
$0.33
$-0.39
Q1 25
$1.60
$-0.38
Q4 24
$0.28
$-0.25
Q3 24
$0.25
$-0.22
Q2 24
$0.28
$-0.26
Q1 24
$0.01
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FEIM
FEIM
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$3.0M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$654.3M
Total Assets
$92.3M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FEIM
FEIM
OCUL
OCUL
Q4 25
$3.0M
$737.1M
Q3 25
$4.5M
$344.8M
Q2 25
$4.7M
$391.1M
Q1 25
$5.5M
$349.7M
Q4 24
$9.7M
$392.1M
Q3 24
$16.2M
$427.2M
Q2 24
$18.3M
$459.7M
Q1 24
$11.7M
$482.9M
Stockholders' Equity
FEIM
FEIM
OCUL
OCUL
Q4 25
$58.5M
$654.3M
Q3 25
$56.3M
$258.2M
Q2 25
$55.6M
$305.9M
Q1 25
$51.8M
$265.9M
Q4 24
$36.2M
$315.3M
Q3 24
$33.2M
$352.0M
Q2 24
$39.8M
$377.7M
Q1 24
$36.7M
$408.0M
Total Assets
FEIM
FEIM
OCUL
OCUL
Q4 25
$92.3M
$808.1M
Q3 25
$93.2M
$410.9M
Q2 25
$93.7M
$451.3M
Q1 25
$86.4M
$405.9M
Q4 24
$77.8M
$457.9M
Q3 24
$84.3M
$490.4M
Q2 24
$83.3M
$517.1M
Q1 24
$77.7M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FEIM
FEIM
OCUL
OCUL
Operating Cash FlowLast quarter
$-523.0K
$-54.2M
Free Cash FlowOCF − Capex
$-1.1M
$-57.1M
FCF MarginFCF / Revenue
-6.6%
-430.9%
Capex IntensityCapex / Revenue
3.6%
21.4%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FEIM
FEIM
OCUL
OCUL
Q4 25
$-523.0K
$-54.2M
Q3 25
$1.2M
$-50.7M
Q2 25
$-155.0K
$-55.2M
Q1 25
$-3.6M
$-44.7M
Q4 24
$3.8M
$-39.4M
Q3 24
$-1.5M
$-36.6M
Q2 24
$7.5M
$-24.8M
Q1 24
$4.2M
$-33.9M
Free Cash Flow
FEIM
FEIM
OCUL
OCUL
Q4 25
$-1.1M
$-57.1M
Q3 25
$385.0K
$-56.7M
Q2 25
$-786.0K
$-56.5M
Q1 25
$-4.0M
$-46.6M
Q4 24
$3.3M
$-39.6M
Q3 24
$-1.8M
$-36.6M
Q2 24
$6.7M
$-25.5M
Q1 24
$3.9M
$-34.1M
FCF Margin
FEIM
FEIM
OCUL
OCUL
Q4 25
-6.6%
-430.9%
Q3 25
2.8%
-390.0%
Q2 25
-3.9%
-419.7%
Q1 25
-20.9%
-435.6%
Q4 24
20.8%
-232.0%
Q3 24
-11.8%
-237.6%
Q2 24
42.8%
-155.4%
Q1 24
28.4%
-231.1%
Capex Intensity
FEIM
FEIM
OCUL
OCUL
Q4 25
3.6%
21.4%
Q3 25
5.6%
41.2%
Q2 25
3.2%
9.3%
Q1 25
1.7%
18.1%
Q4 24
3.3%
1.2%
Q3 24
2.2%
0.6%
Q2 24
5.3%
4.5%
Q1 24
2.3%
1.7%
Cash Conversion
FEIM
FEIM
OCUL
OCUL
Q4 25
-0.29×
Q3 25
1.83×
Q2 25
-0.05×
Q1 25
-0.24×
Q4 24
1.44×
Q3 24
-0.60×
Q2 24
2.85×
Q1 24
32.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FEIM
FEIM

POC Revenue$14.8M86%
POT Revenue$2.3M13%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons